Ingevity Corporation manufactures and sells specialty chemicals and carbon materials in the United States and internationally. The company operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells wood-based chemically activated carbon products primarily for gasoline vapor emission control systems. This segment also produces other activated carbon products for use in various applications, including food, water, beverage, and chemical purification. The Performance Chemicals segment develops, manufactures, and sells a range of specialty chemicals derived from co-products of the Kraft pulping process. This segment's products are used in various applications comprising asphalt paving, oilfield exploration and production, printing inks, adhesives, agrochemical dispersants, lubricants, and other diverse industries. Ingevity Corporation was incorporated in 2015 and is headquartered in North Charleston, South Carolina.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Chemicals & allied products
Sub-IndustryN/A
SectorBasic Materials
SymbolNYSE:NGVT
CUSIPN/A
Phone843-740-2300
Debt
Debt-to-Equity Ratio2.09
Current Ratio2.58
Quick Ratio1.48
Price-To-Earnings
Trailing P/E Ratio38.20
Forward P/E Ratio27.00
P/E Growth2.28
Sales & Book Value
Annual Sales$972.40 million
Price / Sales4.27
Cash Flow$3.5189 per share
Price / Cash28.08
Book Value$6.60 per share
Price / Book14.97
Profitability
EPS (Most Recent Fiscal Year)$2.58
Net Income$126.50 million
Net Margins14.72%
Return on Equity46.65%
Return on Assets12.42%
Miscellaneous
Employees1,500
Outstanding Shares42,050,000
Market Cap$4.21 billion
Ingevity (NYSE:NGVT) Frequently Asked Questions
What is Ingevity's stock symbol?
Ingevity trades on the New York Stock Exchange (NYSE) under the ticker symbol "NGVT."
How were Ingevity's earnings last quarter?
Ingevity Corp (NYSE:NGVT) released its quarterly earnings data on Wednesday, July, 25th. The company reported $1.12 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.99 by $0.13. The business earned $308.60 million during the quarter, compared to analysts' expectations of $305.14 million. Ingevity had a net margin of 14.72% and a return on equity of 46.65%. The company's revenue for the quarter was up 18.6% on a year-over-year basis. During the same period in the previous year, the company earned $0.78 EPS. View Ingevity's Earnings History.
When is Ingevity's next earnings date?
What price target have analysts set for NGVT?
8 brokers have issued 1 year price targets for Ingevity's stock. Their forecasts range from $90.00 to $110.00. On average, they anticipate Ingevity's stock price to reach $99.00 in the next twelve months. This suggests a possible upside of 0.2% from the stock's current price. View Analyst Price Targets for Ingevity.
What is the consensus analysts' recommendation for Ingevity?
8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ingevity in the last year. There are currently 1 hold rating and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Ingevity.
Are investors shorting Ingevity?
Ingevity saw a increase in short interest in the month of July. As of July 31st, there was short interest totalling 1,101,119 shares, an increase of 74.5% from the July 13th total of 630,876 shares. Based on an average daily volume of 357,784 shares, the short-interest ratio is currently 3.1 days. Currently, 2.6% of the company's shares are sold short. View Ingevity's Current Options Chain.
Who are some of Ingevity's key competitors?
Some companies that are related to Ingevity include FMC (FMC), Johnson Matthey (JMPLY), Chemours (CC), Huntsman (HUN), Ashland Global (ASH), Olin (OLN), W. R. Grace & Co (GRA), Univar (UNVR), Balchem (BCPC), PQ Group (PQG), GCP Applied Technologies (GCP), Innospec (IOSP), KMG Chemicals (KMG), OCI Partners (OCIP) and Nexeo Solutions (NXEO).
Who are Ingevity's key executives?
Ingevity's management team includes the folowing people:
- Mr. D. Michael Wilson, Pres, CEO & Director (Age 55)
- Mr. John C. Fortson, Exec. VP, CFO & Treasurer (Age 51)
- Ms. Katherine Pryor Burgeson, Exec. VP, Gen. Counsel & Sec. (Age 60)
- Mr. Stuart Edward Woodcock Jr., Exec. VP & Pres of Performance Materials (Age 52)
- Mr. Michael P. Smith, Exec. VP and Pres of Performance Chemicals, Strategy & Bus. Devel. (Age 57)
Has Ingevity been receiving favorable news coverage?
Press coverage about NGVT stock has been trending somewhat positive on Monday, according to Accern. The research group ranks the sentiment of media coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Ingevity earned a coverage optimism score of 0.20 on Accern's scale. They also gave press coverage about the company an impact score of 46.22 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the next few days. View Recent Headlines for Ingevity.
Who are Ingevity's major shareholders?
Ingevity's stock is owned by many different of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (14.24%), FMR LLC (2.06%), Chilton Investment Co. LLC (2.01%), Massachusetts Financial Services Co. MA (1.97%), Channing Capital Management LLC (1.93%) and Bank of New York Mellon Corp (1.52%). View Institutional Ownership Trends for Ingevity.
Which major investors are selling Ingevity stock?
NGVT stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Assenagon Asset Management S.A., WINTON GROUP Ltd, Chilton Investment Co. LLC, Channing Capital Management LLC, Ardevora Asset Management LLP, BNP Paribas Arbitrage SA and Golden Gate Private Equity Inc.. View Insider Buying and Selling for Ingevity.
Which major investors are buying Ingevity stock?
NGVT stock was bought by a variety of institutional investors in the last quarter, including FMR LLC, BlackRock Inc., Artisan Partners Limited Partnership, Segall Bryant & Hamill LLC, Federated Investors Inc. PA, Waddell & Reed Financial Inc., OppenheimerFunds Inc. and First Trust Advisors LP. View Insider Buying and Selling for Ingevity.
How do I buy shares of Ingevity?
Shares of NGVT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Ingevity's stock price today?
One share of NGVT stock can currently be purchased for approximately $98.81.
How big of a company is Ingevity?
Ingevity has a market capitalization of $4.21 billion and generates $972.40 million in revenue each year. The company earns $126.50 million in net income (profit) each year or $2.58 on an earnings per share basis. Ingevity employs 1,500 workers across the globe.
How can I contact Ingevity?
Ingevity's mailing address is 5255 VIRGINIA AVENUE, NORTH CHARLESTON SC, 29406. The company can be reached via phone at 843-740-2300 or via email at [email protected]
MarketBeat Community Rating for Ingevity (NYSE NGVT)
MarketBeat's community ratings are surveys of what our community members think about Ingevity and other stocks. Vote "Outperform" if you believe NGVT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NGVT will underperform the S&P 500 over the long term. You may vote once every thirty days.
